WAVE Life Sciences Ltd.
WVE
$6.99
-$0.42-5.67%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.54% | -5.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.54% | -5.19% | |||
| Cost of Revenue | 5.53% | 7.01% | |||
| Gross Profit | -10.05% | -10.57% | |||
| SG&A Expenses | 0.54% | -2.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.07% | 4.20% | |||
| Operating Income | -6.81% | -5.93% | |||
| Income Before Tax | -6.70% | -7.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.70% | -7.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.70% | -7.66% | |||
| EBIT | -6.81% | -5.93% | |||
| EBITDA | -6.94% | -6.06% | |||
| EPS Basic | -4.29% | -6.73% | |||
| Normalized Basic EPS | -4.31% | -6.71% | |||
| EPS Diluted | -4.29% | -6.73% | |||
| Normalized Diluted EPS | -4.31% | -6.71% | |||
| Average Basic Shares Outstanding | 2.29% | 0.90% | |||
| Average Diluted Shares Outstanding | 2.29% | 0.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||